nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A4—type 2 diabetes mellitus	0.122	1	CbGaD
Triazolam—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0351	0.064	CbGbCtD
Triazolam—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.028	0.0512	CbGbCtD
Triazolam—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0267	0.0486	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0267	0.0486	CbGbCtD
Triazolam—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0254	0.0463	CbGbCtD
Triazolam—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0245	0.0446	CbGbCtD
Triazolam—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0234	0.0427	CbGbCtD
Triazolam—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0226	0.0412	CbGbCtD
Triazolam—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0224	0.0408	CbGbCtD
Triazolam—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0208	0.038	CbGbCtD
Triazolam—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.02	0.0365	CbGbCtD
Triazolam—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0184	0.0336	CbGbCtD
Triazolam—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0177	0.0323	CbGbCtD
Triazolam—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0177	0.0323	CbGbCtD
Triazolam—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0163	0.0298	CbGbCtD
Triazolam—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.016	0.0291	CbGbCtD
Triazolam—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0158	0.0288	CbGbCtD
Triazolam—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0144	0.0263	CbGbCtD
Triazolam—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0142	0.026	CbGbCtD
Triazolam—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0134	0.0245	CbGbCtD
Triazolam—CYP3A4—Glipizide—type 2 diabetes mellitus	0.013	0.0237	CbGbCtD
Triazolam—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0129	0.0234	CbGbCtD
Triazolam—CYP3A5—Losartan—type 2 diabetes mellitus	0.0124	0.0225	CbGbCtD
Triazolam—CYP2C8—Losartan—type 2 diabetes mellitus	0.0119	0.0217	CbGbCtD
Triazolam—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0114	0.0207	CbGbCtD
Triazolam—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0188	CbGbCtD
Triazolam—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00906	0.0165	CbGbCtD
Triazolam—CYP2C9—Losartan—type 2 diabetes mellitus	0.00828	0.0151	CbGbCtD
Triazolam—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0078	0.0142	CbGbCtD
Triazolam—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00747	0.0136	CbGbCtD
Triazolam—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00747	0.0136	CbGbCtD
Triazolam—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00707	0.0129	CbGbCtD
Triazolam—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00527	0.00961	CbGbCtD
Triazolam—CYP3A4—Losartan—type 2 diabetes mellitus	0.00482	0.00879	CbGbCtD
Triazolam—GABRR3—peripheral nervous system—type 2 diabetes mellitus	0.00479	0.095	CbGeAlD
Triazolam—GABRR2—peripheral nervous system—type 2 diabetes mellitus	0.00415	0.0823	CbGeAlD
Triazolam—GABRR1—peripheral nervous system—type 2 diabetes mellitus	0.00399	0.0793	CbGeAlD
Triazolam—GABRR3—nerve—type 2 diabetes mellitus	0.00373	0.074	CbGeAlD
Triazolam—GABRQ—nerve—type 2 diabetes mellitus	0.00373	0.074	CbGeAlD
Triazolam—GABRR2—nerve—type 2 diabetes mellitus	0.00323	0.0642	CbGeAlD
Triazolam—GABRR1—nerve—type 2 diabetes mellitus	0.00311	0.0618	CbGeAlD
Triazolam—TSPO—hindlimb—type 2 diabetes mellitus	0.00265	0.0526	CbGeAlD
Triazolam—TSPO—artery—type 2 diabetes mellitus	0.00163	0.0323	CbGeAlD
Triazolam—GABRR3—retina—type 2 diabetes mellitus	0.00155	0.0307	CbGeAlD
Triazolam—GABRR2—retina—type 2 diabetes mellitus	0.00134	0.0266	CbGeAlD
Triazolam—GABRR1—retina—type 2 diabetes mellitus	0.00129	0.0256	CbGeAlD
Triazolam—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000941	0.0187	CbGeAlD
Triazolam—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000805	0.016	CbGeAlD
Triazolam—TSPO—islet of Langerhans—type 2 diabetes mellitus	0.000781	0.0155	CbGeAlD
Triazolam—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.000709	0.0141	CbGeAlD
Triazolam—TSPO—retina—type 2 diabetes mellitus	0.000668	0.0133	CbGeAlD
Triazolam—TSPO—nephron tubule—type 2 diabetes mellitus	0.000629	0.0125	CbGeAlD
Triazolam—CYP3A7—liver—type 2 diabetes mellitus	0.000615	0.0122	CbGeAlD
Triazolam—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.000581	0.0115	CbGeAlD
Triazolam—TSPO—cardiovascular system—type 2 diabetes mellitus	0.000565	0.0112	CbGeAlD
Triazolam—TSPO—kidney—type 2 diabetes mellitus	0.000553	0.011	CbGeAlD
Triazolam—TSPO—pancreas—type 2 diabetes mellitus	0.000549	0.0109	CbGeAlD
Triazolam—TSPO—cortex of kidney—type 2 diabetes mellitus	0.000538	0.0107	CbGeAlD
Triazolam—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000538	0.0107	CbGeAlD
Triazolam—GABRE—adipose tissue—type 2 diabetes mellitus	0.000534	0.0106	CbGeAlD
Triazolam—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000523	0.0104	CbGeAlD
Triazolam—GABRB3—pancreas—type 2 diabetes mellitus	0.000499	0.00989	CbGeAlD
Triazolam—TSPO—adipose tissue—type 2 diabetes mellitus	0.000498	0.00989	CbGeAlD
Triazolam—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000484	0.0096	CbGeAlD
Triazolam—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.00039	0.00773	CbGeAlD
Triazolam—CYP2C8—kidney—type 2 diabetes mellitus	0.000379	0.00753	CbGeAlD
Triazolam—TSPO—liver—type 2 diabetes mellitus	0.000349	0.00693	CbGeAlD
Triazolam—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000344	0.00683	CbGeAlD
Triazolam—CYP3A5—kidney—type 2 diabetes mellitus	0.000342	0.00679	CbGeAlD
Triazolam—CYP3A5—pancreas—type 2 diabetes mellitus	0.00034	0.00675	CbGeAlD
Triazolam—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000333	0.00662	CbGeAlD
Triazolam—GABRB3—liver—type 2 diabetes mellitus	0.000317	0.00629	CbGeAlD
Triazolam—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000309	0.00612	CbGeAlD
Triazolam—CYP3A4—kidney—type 2 diabetes mellitus	0.000257	0.0051	CbGeAlD
Triazolam—CYP2C8—liver—type 2 diabetes mellitus	0.00024	0.00476	CbGeAlD
Triazolam—Anxiety—Orlistat—type 2 diabetes mellitus	0.000223	0.00122	CcSEcCtD
Triazolam—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Triazolam—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Triazolam—Discomfort—Orlistat—type 2 diabetes mellitus	0.000221	0.00121	CcSEcCtD
Triazolam—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00022	0.00121	CcSEcCtD
Triazolam—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Triazolam—Malaise—Metformin—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Triazolam—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Triazolam—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000218	0.0012	CcSEcCtD
Triazolam—Vomiting—Glipizide—type 2 diabetes mellitus	0.000218	0.00119	CcSEcCtD
Triazolam—Syncope—Metformin—type 2 diabetes mellitus	0.000218	0.00119	CcSEcCtD
Triazolam—Oedema—Valsartan—type 2 diabetes mellitus	0.000217	0.00119	CcSEcCtD
Triazolam—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000217	0.00119	CcSEcCtD
Triazolam—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000217	0.00119	CcSEcCtD
Triazolam—CYP3A5—liver—type 2 diabetes mellitus	0.000216	0.00429	CbGeAlD
Triazolam—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000216	0.00118	CcSEcCtD
Triazolam—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Triazolam—Erythema—Losartan—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Triazolam—Oedema—Orlistat—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Triazolam—Headache—Glipizide—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Triazolam—Tremor—Irbesartan—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Triazolam—Palpitations—Metformin—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Triazolam—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000214	0.00117	CcSEcCtD
Triazolam—Shock—Valsartan—type 2 diabetes mellitus	0.000214	0.00117	CcSEcCtD
Triazolam—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000213	0.00117	CcSEcCtD
Triazolam—CYP2C9—liver—type 2 diabetes mellitus	0.000213	0.00423	CbGeAlD
Triazolam—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000212	0.00117	CcSEcCtD
Triazolam—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000212	0.00116	CcSEcCtD
Triazolam—Flatulence—Losartan—type 2 diabetes mellitus	0.000212	0.00116	CcSEcCtD
Triazolam—Tension—Losartan—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Triazolam—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Triazolam—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Triazolam—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Triazolam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Triazolam—Agitation—Irbesartan—type 2 diabetes mellitus	0.00021	0.00115	CcSEcCtD
Triazolam—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00021	0.00115	CcSEcCtD
Triazolam—Hypertension—Metformin—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Triazolam—Nervousness—Losartan—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Triazolam—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Triazolam—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Triazolam—Anorexia—Valsartan—type 2 diabetes mellitus	0.000207	0.00114	CcSEcCtD
Triazolam—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000207	0.00114	CcSEcCtD
Triazolam—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00113	CcSEcCtD
Triazolam—Chest pain—Metformin—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Triazolam—Malaise—Irbesartan—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Triazolam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000205	0.00113	CcSEcCtD
Triazolam—Syncope—Irbesartan—type 2 diabetes mellitus	0.000205	0.00113	CcSEcCtD
Triazolam—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000204	0.00112	CcSEcCtD
Triazolam—Discomfort—Metformin—type 2 diabetes mellitus	0.000204	0.00112	CcSEcCtD
Triazolam—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000204	0.00112	CcSEcCtD
Triazolam—Nausea—Glipizide—type 2 diabetes mellitus	0.000203	0.00112	CcSEcCtD
Triazolam—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000203	0.00111	CcSEcCtD
Triazolam—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00111	CcSEcCtD
Triazolam—Pain—Gliclazide—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Triazolam—Constipation—Gliclazide—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Triazolam—Tremor—Losartan—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Triazolam—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Triazolam—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Triazolam—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Triazolam—Headache—Glimepiride—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Triazolam—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Triazolam—Headache—Sitagliptin—type 2 diabetes mellitus	0.0002	0.00109	CcSEcCtD
Triazolam—Agitation—Losartan—type 2 diabetes mellitus	0.000198	0.00109	CcSEcCtD
Triazolam—Oedema—Metformin—type 2 diabetes mellitus	0.000198	0.00109	CcSEcCtD
Triazolam—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000198	0.00109	CcSEcCtD
Triazolam—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000198	0.00108	CcSEcCtD
Triazolam—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00108	CcSEcCtD
Triazolam—Insomnia—Valsartan—type 2 diabetes mellitus	0.000197	0.00108	CcSEcCtD
Triazolam—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Triazolam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Triazolam—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Triazolam—Shock—Metformin—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Triazolam—Insomnia—Orlistat—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Triazolam—Malaise—Losartan—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Triazolam—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Triazolam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Triazolam—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Triazolam—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Triazolam—Somnolence—Valsartan—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Triazolam—Syncope—Losartan—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Triazolam—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Triazolam—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Triazolam—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000191	0.00105	CcSEcCtD
Triazolam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00105	CcSEcCtD
Triazolam—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000191	0.00105	CcSEcCtD
Triazolam—Palpitations—Losartan—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Triazolam—Nausea—Glimepiride—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Triazolam—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Triazolam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Triazolam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Triazolam—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Triazolam—Anorexia—Metformin—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Triazolam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Triazolam—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Triazolam—Oedema—Irbesartan—type 2 diabetes mellitus	0.000187	0.00102	CcSEcCtD
Triazolam—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000187	0.00102	CcSEcCtD
Triazolam—Pruritus—Glyburide—type 2 diabetes mellitus	0.000186	0.00102	CcSEcCtD
Triazolam—Constipation—Valsartan—type 2 diabetes mellitus	0.000186	0.00102	CcSEcCtD
Triazolam—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000186	0.0727	CrCbGaD
Triazolam—Fatigue—Orlistat—type 2 diabetes mellitus	0.000185	0.00102	CcSEcCtD
Triazolam—Erythema—Ramipril—type 2 diabetes mellitus	0.000185	0.00101	CcSEcCtD
Triazolam—Shock—Irbesartan—type 2 diabetes mellitus	0.000184	0.00101	CcSEcCtD
Triazolam—Pain—Orlistat—type 2 diabetes mellitus	0.000184	0.00101	CcSEcCtD
Triazolam—Chest pain—Losartan—type 2 diabetes mellitus	0.000183	0.00101	CcSEcCtD
Triazolam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00101	CcSEcCtD
Triazolam—Anxiety—Losartan—type 2 diabetes mellitus	0.000183	0.001	CcSEcCtD
Triazolam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000182	0.001	CcSEcCtD
Triazolam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000182	0.000996	CcSEcCtD
Triazolam—Tension—Ramipril—type 2 diabetes mellitus	0.000181	0.000994	CcSEcCtD
Triazolam—Discomfort—Losartan—type 2 diabetes mellitus	0.000181	0.000994	CcSEcCtD
Triazolam—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000181	0.000992	CcSEcCtD
Triazolam—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000181	0.000991	CcSEcCtD
Triazolam—Headache—Bromocriptine—type 2 diabetes mellitus	0.000181	0.00099	CcSEcCtD
Triazolam—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00018	0.000989	CcSEcCtD
Triazolam—Nervousness—Ramipril—type 2 diabetes mellitus	0.000179	0.000984	CcSEcCtD
Triazolam—Dry mouth—Losartan—type 2 diabetes mellitus	0.000179	0.000984	CcSEcCtD
Triazolam—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000178	0.000977	CcSEcCtD
Triazolam—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000178	0.000975	CcSEcCtD
Triazolam—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000178	0.000975	CcSEcCtD
Triazolam—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000178	0.000974	CcSEcCtD
Triazolam—Confusional state—Losartan—type 2 diabetes mellitus	0.000177	0.000972	CcSEcCtD
Triazolam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000177	0.000971	CcSEcCtD
Triazolam—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000176	0.000968	CcSEcCtD
Triazolam—Somnolence—Metformin—type 2 diabetes mellitus	0.000176	0.000965	CcSEcCtD
Triazolam—Oedema—Losartan—type 2 diabetes mellitus	0.000176	0.000964	CcSEcCtD
Triazolam—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000176	0.000963	CcSEcCtD
Triazolam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000174	0.000956	CcSEcCtD
Triazolam—Tremor—Ramipril—type 2 diabetes mellitus	0.000173	0.000949	CcSEcCtD
Triazolam—Shock—Losartan—type 2 diabetes mellitus	0.000173	0.000949	CcSEcCtD
Triazolam—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000172	0.000944	CcSEcCtD
Triazolam—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000172	0.000943	CcSEcCtD
Triazolam—Tachycardia—Losartan—type 2 diabetes mellitus	0.000172	0.000941	CcSEcCtD
Triazolam—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000171	0.00094	CcSEcCtD
Triazolam—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000939	CcSEcCtD
Triazolam—Fatigue—Metformin—type 2 diabetes mellitus	0.000171	0.000936	CcSEcCtD
Triazolam—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00017	0.000932	CcSEcCtD
Triazolam—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00017	0.000931	CcSEcCtD
Triazolam—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00017	0.000931	CcSEcCtD
Triazolam—Agitation—Ramipril—type 2 diabetes mellitus	0.00017	0.000931	CcSEcCtD
Triazolam—Constipation—Metformin—type 2 diabetes mellitus	0.000169	0.000929	CcSEcCtD
Triazolam—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000168	0.00092	CcSEcCtD
Triazolam—Anorexia—Losartan—type 2 diabetes mellitus	0.000168	0.000919	CcSEcCtD
Triazolam—Vomiting—Glyburide—type 2 diabetes mellitus	0.000168	0.000919	CcSEcCtD
Triazolam—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000167	0.000918	CcSEcCtD
Triazolam—Malaise—Ramipril—type 2 diabetes mellitus	0.000167	0.000914	CcSEcCtD
Triazolam—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000167	0.000914	CcSEcCtD
Triazolam—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000166	0.000911	CcSEcCtD
Triazolam—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000166	0.00091	CcSEcCtD
Triazolam—Syncope—Ramipril—type 2 diabetes mellitus	0.000166	0.000909	CcSEcCtD
Triazolam—Headache—Glyburide—type 2 diabetes mellitus	0.000165	0.000905	CcSEcCtD
Triazolam—Palpitations—Ramipril—type 2 diabetes mellitus	0.000163	0.000895	CcSEcCtD
Triazolam—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000163	0.000895	CcSEcCtD
Triazolam—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000162	0.000891	CcSEcCtD
Triazolam—CYP3A4—liver—type 2 diabetes mellitus	0.000162	0.00322	CbGeAlD
Triazolam—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000162	0.00089	CcSEcCtD
Triazolam—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000162	0.000888	CcSEcCtD
Triazolam—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000162	0.000888	CcSEcCtD
Triazolam—Chlorprothixene—HTR2C—type 2 diabetes mellitus	0.000162	0.0632	CrCbGaD
Triazolam—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000161	0.000883	CcSEcCtD
Triazolam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00016	0.000878	CcSEcCtD
Triazolam—Pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000876	CcSEcCtD
Triazolam—Constipation—Irbesartan—type 2 diabetes mellitus	0.00016	0.000876	CcSEcCtD
Triazolam—Insomnia—Losartan—type 2 diabetes mellitus	0.000159	0.000872	CcSEcCtD
Triazolam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000158	0.000868	CcSEcCtD
Triazolam—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000158	0.000866	CcSEcCtD
Triazolam—Chest pain—Ramipril—type 2 diabetes mellitus	0.000157	0.000863	CcSEcCtD
Triazolam—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000157	0.00086	CcSEcCtD
Triazolam—Anxiety—Ramipril—type 2 diabetes mellitus	0.000157	0.00086	CcSEcCtD
Triazolam—Nausea—Glyburide—type 2 diabetes mellitus	0.000157	0.000858	CcSEcCtD
Triazolam—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000156	0.000858	CcSEcCtD
Triazolam—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000156	0.000858	CcSEcCtD
Triazolam—Somnolence—Losartan—type 2 diabetes mellitus	0.000156	0.000857	CcSEcCtD
Triazolam—Asthenia—Valsartan—type 2 diabetes mellitus	0.000156	0.000855	CcSEcCtD
Triazolam—Discomfort—Ramipril—type 2 diabetes mellitus	0.000155	0.000852	CcSEcCtD
Triazolam—Asthenia—Orlistat—type 2 diabetes mellitus	0.000154	0.000845	CcSEcCtD
Triazolam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000154	0.000844	CcSEcCtD
Triazolam—Pruritus—Valsartan—type 2 diabetes mellitus	0.000154	0.000844	CcSEcCtD
Triazolam—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000154	0.000844	CcSEcCtD
Triazolam—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000153	0.000838	CcSEcCtD
Triazolam—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000153	0.000838	CcSEcCtD
Triazolam—Confusional state—Ramipril—type 2 diabetes mellitus	0.000152	0.000834	CcSEcCtD
Triazolam—Pruritus—Orlistat—type 2 diabetes mellitus	0.000152	0.000834	CcSEcCtD
Triazolam—Fatigue—Losartan—type 2 diabetes mellitus	0.000152	0.000831	CcSEcCtD
Triazolam—Oedema—Ramipril—type 2 diabetes mellitus	0.000151	0.000827	CcSEcCtD
Triazolam—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00015	0.000825	CcSEcCtD
Triazolam—Pain—Losartan—type 2 diabetes mellitus	0.00015	0.000825	CcSEcCtD
Triazolam—Constipation—Losartan—type 2 diabetes mellitus	0.00015	0.000825	CcSEcCtD
Triazolam—Flunitrazepam—CYP2E1—type 2 diabetes mellitus	0.000149	0.0583	CrCbGaD
Triazolam—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000149	0.000818	CcSEcCtD
Triazolam—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000149	0.000816	CcSEcCtD
Triazolam—Shock—Ramipril—type 2 diabetes mellitus	0.000148	0.000814	CcSEcCtD
Triazolam—Headache—Gliclazide—type 2 diabetes mellitus	0.000148	0.000813	CcSEcCtD
Triazolam—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000148	0.00081	CcSEcCtD
Triazolam—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000147	0.000807	CcSEcCtD
Triazolam—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000147	0.000806	CcSEcCtD
Triazolam—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000146	0.000799	CcSEcCtD
Triazolam—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000145	0.000795	CcSEcCtD
Triazolam—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000144	0.000789	CcSEcCtD
Triazolam—Dizziness—Valsartan—type 2 diabetes mellitus	0.000144	0.000788	CcSEcCtD
Triazolam—Anorexia—Ramipril—type 2 diabetes mellitus	0.000144	0.000788	CcSEcCtD
Triazolam—Dizziness—Orlistat—type 2 diabetes mellitus	0.000142	0.000779	CcSEcCtD
Triazolam—Asthenia—Metformin—type 2 diabetes mellitus	0.000142	0.000779	CcSEcCtD
Triazolam—Flunitrazepam—CYP1A2—type 2 diabetes mellitus	0.000142	0.0555	CrCbGaD
Triazolam—Nausea—Gliclazide—type 2 diabetes mellitus	0.000141	0.000771	CcSEcCtD
Triazolam—Pruritus—Metformin—type 2 diabetes mellitus	0.00014	0.000768	CcSEcCtD
Triazolam—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000139	0.000762	CcSEcCtD
Triazolam—Vomiting—Valsartan—type 2 diabetes mellitus	0.000138	0.000758	CcSEcCtD
Triazolam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000138	0.000755	CcSEcCtD
Triazolam—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000137	0.000751	CcSEcCtD
Triazolam—Vomiting—Orlistat—type 2 diabetes mellitus	0.000137	0.000749	CcSEcCtD
Triazolam—Insomnia—Ramipril—type 2 diabetes mellitus	0.000136	0.000748	CcSEcCtD
Triazolam—Headache—Valsartan—type 2 diabetes mellitus	0.000136	0.000747	CcSEcCtD
Triazolam—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000135	0.000743	CcSEcCtD
Triazolam—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000135	0.000742	CcSEcCtD
Triazolam—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000135	0.000742	CcSEcCtD
Triazolam—Headache—Orlistat—type 2 diabetes mellitus	0.000135	0.000738	CcSEcCtD
Triazolam—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000134	0.000737	CcSEcCtD
Triazolam—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000134	0.000735	CcSEcCtD
Triazolam—Somnolence—Ramipril—type 2 diabetes mellitus	0.000134	0.000735	CcSEcCtD
Triazolam—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000132	0.000725	CcSEcCtD
Triazolam—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000131	0.000719	CcSEcCtD
Triazolam—Dizziness—Metformin—type 2 diabetes mellitus	0.000131	0.000718	CcSEcCtD
Triazolam—Fatigue—Ramipril—type 2 diabetes mellitus	0.00013	0.000713	CcSEcCtD
Triazolam—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00013	0.00071	CcSEcCtD
Triazolam—Nausea—Valsartan—type 2 diabetes mellitus	0.000129	0.000708	CcSEcCtD
Triazolam—Constipation—Ramipril—type 2 diabetes mellitus	0.000129	0.000707	CcSEcCtD
Triazolam—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000128	0.000701	CcSEcCtD
Triazolam—Nausea—Orlistat—type 2 diabetes mellitus	0.000128	0.0007	CcSEcCtD
Triazolam—Asthenia—Losartan—type 2 diabetes mellitus	0.000126	0.000692	CcSEcCtD
Triazolam—Vomiting—Metformin—type 2 diabetes mellitus	0.000126	0.00069	CcSEcCtD
Triazolam—Dermatitis—Metformin—type 2 diabetes mellitus	0.000125	0.000684	CcSEcCtD
Triazolam—Pruritus—Losartan—type 2 diabetes mellitus	0.000124	0.000682	CcSEcCtD
Triazolam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000124	0.000681	CcSEcCtD
Triazolam—Headache—Metformin—type 2 diabetes mellitus	0.000124	0.00068	CcSEcCtD
Triazolam—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000124	0.000678	CcSEcCtD
Triazolam—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000123	0.000676	CcSEcCtD
Triazolam—Chlordiazepoxide—CYP3A4—type 2 diabetes mellitus	0.000121	0.0474	CrCbGaD
Triazolam—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00012	0.00066	CcSEcCtD
Triazolam—Flurazepam—CYP2E1—type 2 diabetes mellitus	0.00012	0.0468	CrCbGaD
Triazolam—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000119	0.000654	CcSEcCtD
Triazolam—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000119	0.000652	CcSEcCtD
Triazolam—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000118	0.000645	CcSEcCtD
Triazolam—Nausea—Metformin—type 2 diabetes mellitus	0.000118	0.000645	CcSEcCtD
Triazolam—Headache—Irbesartan—type 2 diabetes mellitus	0.000117	0.000642	CcSEcCtD
Triazolam—Clonazepam—CYP3A4—type 2 diabetes mellitus	0.000117	0.0458	CrCbGaD
Triazolam—Dizziness—Losartan—type 2 diabetes mellitus	0.000116	0.000638	CcSEcCtD
Triazolam—Vomiting—Losartan—type 2 diabetes mellitus	0.000112	0.000613	CcSEcCtD
Triazolam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000111	0.000609	CcSEcCtD
Triazolam—Nausea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000609	CcSEcCtD
Triazolam—Midazolam—CYP2E1—type 2 diabetes mellitus	0.000111	0.0434	CrCbGaD
Triazolam—Dermatitis—Losartan—type 2 diabetes mellitus	0.000111	0.000607	CcSEcCtD
Triazolam—Headache—Losartan—type 2 diabetes mellitus	0.00011	0.000604	CcSEcCtD
Triazolam—Clotiazepam—CYP3A4—type 2 diabetes mellitus	0.000109	0.0425	CrCbGaD
Triazolam—Asthenia—Ramipril—type 2 diabetes mellitus	0.000108	0.000593	CcSEcCtD
Triazolam—Pruritus—Ramipril—type 2 diabetes mellitus	0.000107	0.000585	CcSEcCtD
Triazolam—Nausea—Losartan—type 2 diabetes mellitus	0.000104	0.000573	CcSEcCtD
Triazolam—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000103	0.000566	CcSEcCtD
Triazolam—Alprazolam—CYP3A4—type 2 diabetes mellitus	0.000103	0.0401	CrCbGaD
Triazolam—Clobazam—CYP3A4—type 2 diabetes mellitus	0.000103	0.0401	CrCbGaD
Triazolam—Clonazepam—ALB—type 2 diabetes mellitus	0.000102	0.0399	CrCbGaD
Triazolam—Dizziness—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000547	CcSEcCtD
Triazolam—Quazepam—CYP3A4—type 2 diabetes mellitus	9.94e-05	0.0389	CrCbGaD
Triazolam—Vomiting—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000526	CcSEcCtD
Triazolam—Diazepam—CYP2E1—type 2 diabetes mellitus	9.5e-05	0.0372	CrCbGaD
Triazolam—Dermatitis—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000521	CcSEcCtD
Triazolam—Headache—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000518	CcSEcCtD
Triazolam—Flunitrazepam—CYP3A4—type 2 diabetes mellitus	9.39e-05	0.0367	CrCbGaD
Triazolam—Diazepam—CYP1A2—type 2 diabetes mellitus	9.04e-05	0.0354	CrCbGaD
Triazolam—Nausea—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000491	CcSEcCtD
Triazolam—Estazolam—CYP3A4—type 2 diabetes mellitus	8.78e-05	0.0344	CrCbGaD
Triazolam—Adinazolam—CYP3A4—type 2 diabetes mellitus	8.36e-05	0.0327	CrCbGaD
Triazolam—Prazepam—CYP3A4—type 2 diabetes mellitus	8.08e-05	0.0316	CrCbGaD
Triazolam—Flurazepam—CYP3A4—type 2 diabetes mellitus	7.53e-05	0.0295	CrCbGaD
Triazolam—Oxazepam—CYP3A4—type 2 diabetes mellitus	7.3e-05	0.0286	CrCbGaD
Triazolam—Temazepam—CYP3A4—type 2 diabetes mellitus	7.2e-05	0.0282	CrCbGaD
Triazolam—Midazolam—CYP3A4—type 2 diabetes mellitus	6.99e-05	0.0273	CrCbGaD
Triazolam—Diazepam—CYP3A4—type 2 diabetes mellitus	5.99e-05	0.0234	CrCbGaD
Triazolam—Diazepam—ALB—type 2 diabetes mellitus	5.22e-05	0.0204	CrCbGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.46e-06	7.87e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	7.45e-06	7.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.28e-06	7.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.26e-06	7.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.26e-06	7.66e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.16e-06	7.55e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	7.16e-06	7.55e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	7.13e-06	7.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	7.1e-06	7.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.09e-06	7.47e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	7.03e-06	7.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.01e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.01e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.01e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.01e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.01e-06	7.4e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	7.01e-06	7.39e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	6.93e-06	7.3e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	6.93e-06	7.3e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	6.93e-06	7.3e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	6.86e-06	7.24e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	6.86e-06	7.24e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	6.85e-06	7.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	6.85e-06	7.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	6.85e-06	7.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	6.85e-06	7.23e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	6.83e-06	7.2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	6.8e-06	7.17e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.79e-06	7.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	6.74e-06	7.11e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	6.73e-06	7.1e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.69e-06	7.06e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	6.69e-06	7.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	6.69e-06	7.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	6.69e-06	7.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	6.65e-06	7.01e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	6.64e-06	7e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	6.59e-06	6.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.59e-06	6.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	6.57e-06	6.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	6.53e-06	6.88e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	6.52e-06	6.87e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	6.45e-06	6.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.41e-06	6.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.41e-06	6.76e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	6.38e-06	6.73e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.38e-06	6.73e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	6.36e-06	6.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	6.34e-06	6.68e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	6.26e-06	6.61e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	6.26e-06	6.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.25e-06	6.59e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.25e-06	6.59e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	6.19e-06	6.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.18e-06	6.52e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.12e-06	6.45e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.11e-06	6.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.11e-06	6.44e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.02e-06	6.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.01e-06	6.33e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.01e-06	6.33e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	6e-06	6.33e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	6e-06	6.33e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	6e-06	6.33e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.96e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.96e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.96e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	5.89e-06	6.21e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	5.87e-06	6.19e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	5.84e-06	6.15e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	5.76e-06	6.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.76e-06	6.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.72e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.72e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	5.71e-06	6.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.7e-06	6.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.59e-06	5.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.59e-06	5.89e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	5.58e-06	5.88e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.5e-06	5.8e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.5e-06	5.8e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	5.49e-06	5.79e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.48e-06	5.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.48e-06	5.78e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.47e-06	5.76e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.45e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.44e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.44e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.44e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.43e-06	5.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.43e-06	5.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.41e-06	5.71e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.41e-06	5.7e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.4e-06	5.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.32e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.32e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.32e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.31e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.29e-06	5.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.26e-06	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.25e-06	5.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	5.2e-06	5.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	5.2e-06	5.49e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.18e-06	5.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.18e-06	5.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.15e-06	5.43e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.08e-06	5.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5e-06	5.27e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	4.94e-06	5.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.9e-06	5.16e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.88e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.88e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.88e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.8e-06	5.06e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.79e-06	5.05e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.76e-06	5.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.75e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.71e-06	4.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.68e-06	4.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.68e-06	4.93e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.67e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.65e-06	4.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.61e-06	4.87e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.6e-06	4.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.52e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.52e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.52e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.52e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.48e-06	4.73e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.48e-06	4.73e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.48e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.47e-06	4.71e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.46e-06	4.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.42e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.42e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.42e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.4e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.33e-06	4.57e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.31e-06	4.54e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.28e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.28e-06	4.51e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.28e-06	4.51e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.24e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.23e-06	4.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.23e-06	4.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.16e-06	4.39e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.16e-06	4.39e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.09e-06	4.32e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.09e-06	4.32e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.08e-06	4.3e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.03e-06	4.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.03e-06	4.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4e-06	4.21e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.98e-06	4.2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.96e-06	4.18e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.95e-06	4.17e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.91e-06	4.12e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.88e-06	4.09e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.83e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.76e-06	3.97e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.74e-06	3.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.68e-06	3.89e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.68e-06	3.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.68e-06	3.88e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.65e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.65e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.63e-06	3.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.61e-06	3.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.61e-06	3.8e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.59e-06	3.79e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.59e-06	3.79e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.59e-06	3.79e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.58e-06	3.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.57e-06	3.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.5e-06	3.7e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.49e-06	3.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.48e-06	3.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.46e-06	3.65e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.44e-06	3.63e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.43e-06	3.62e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.42e-06	3.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.38e-06	3.57e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.38e-06	3.57e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.37e-06	3.56e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.32e-06	3.5e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.25e-06	3.43e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.24e-06	3.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.22e-06	3.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.22e-06	3.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.22e-06	3.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.16e-06	3.33e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.16e-06	3.33e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.13e-06	3.3e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.12e-06	3.29e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.09e-06	3.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.07e-06	3.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.99e-06	3.15e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.98e-06	3.14e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.96e-06	3.12e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.96e-06	3.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.95e-06	3.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.93e-06	3.09e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.92e-06	3.08e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.91e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.91e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.84e-06	3e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.79e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.79e-06	2.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.79e-06	2.94e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.78e-06	2.94e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.75e-06	2.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.71e-06	2.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.68e-06	2.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.56e-06	2.7e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.56e-06	2.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.43e-06	2.56e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-06	2.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-06	2.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-06	2.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.38e-06	2.51e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.36e-06	2.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.34e-06	2.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.29e-06	2.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.23e-06	2.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.19e-06	2.31e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	2.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-06	2.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-06	2.25e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.09e-06	2.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.09e-06	2.2e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.08e-06	2.2e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-06	2.17e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.97e-06	2.08e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-06	2.04e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	2.01e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.88e-06	1.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.87e-06	1.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.84e-06	1.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.84e-06	1.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	1.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	1.69e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	1.65e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	1.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.36e-06	1.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	1.33e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.59e-07	1.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.32e-07	6.67e-06	CbGpPWpGaD
